The U.S. cannabis industry is being reshaped by a new wave of mergers and acquisitions. Facing onerous federal tax burdens under Section 280E, tightening credit markets, and rising competition from non‑cannabis players, multistate operators and investors are seizing opportunities to consolidate in viable markets while distressed regional businesses exit or restructure. Connecticut: Budr’s Regional Expansion via…

In an industry where women held approximately 39% of executive positions in 2023, yet only 16–22% of business ownership, a growing number of women are leading some of the most innovative and high‑growth cannabis businesses in the United States. We’ve highlighted ten standout companies helmed by female executives who combine leadership, advocacy, analytics, and consumer‑focused…

In a fiercely competitive and heavily regulated industry, not all cannabis companies are created equal. While thousands of licensed businesses operate across the U.S. and Canada, only a select few consistently outperform the rest. These top-tier cannabis companies have established themselves through strategic execution, operational discipline, innovation, and consumer trust. What exactly are they doing…

As the legal cannabis market matures, companies are increasingly stepping up to support social equity programs—efforts designed to address the lasting harms of prohibition by empowering individuals and communities disproportionately affected by the war on drugs. Impact Funding and Loan Programs Technical Assistance and Training Support State‑Company Partnerships: Licensing and Oversight Equity Certification, Networking &…

As prospects for federal legalization edge closer, U.S. cannabis companies are proactively aligning their operations, financial models, and product pipelines to thrive under a potential Schedule III framework. Regulatory & Legal Preparedness The longstanding barrier of cannabis being classified as a Schedule I drug continues to restrict industry growth. Proposals to reclassify cannabis to Schedule III are awaiting…

As the U.S. legal cannabis industry gears toward $45 billion in revenue in 2025 and beyond, ten companies stand out as dominant multi‑state operators and market innovators. 1. Curaleaf Holdings Inc. Website: curaleaf.comCuraleaf is the largest U.S. cannabis company by revenue, generating over $1.3 billion in 2024 and operating in 19 states with more than 140 retail…